STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,200,000 | -56.5% | 3,347,141 | -4.4% | 2.56% | -39.2% |
| Q4 2019 | $37,205,000 | +38.4% | 3,500,000 | +35.5% | 4.20% | +70.6% |
| Q3 2019 | $26,883,000 | -37.9% | 2,582,433 | -8.6% | 2.46% | -27.7% |
| Q2 2019 | $43,301,000 | +12.1% | 2,826,404 | -5.9% | 3.41% | -5.4% |
| Q1 2019 | $38,614,000 | – | 3,005,000 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |